Reply to Giménez et al

Affiliations

Comment

Lynn El Haddad et al. J Infect Dis. 2019.

. 2019 Apr 16;219(9):1512-1513.

doi: 10.1093/infdis/jiy687.

¹ Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.

No abstract available

Comment on

The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. El Haddad L, et al. J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592. J Infect Dis. 2019. PMID: 30295846 Free PMC article.
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Giménez E, Solano C, Piñana JL, Poch M, Mateo E, Albert E, Hernández-Boluda JC, Amat P, Remigia MJ, Pérez A, Navarro D. Giménez E, et al. J Infect Dis. 2019 Apr 16;219(9):1510-1512. doi: 10.1093/infdis/jiy746. J Infect Dis. 2019. PMID: 30597050 No abstract available.

1. Kumar D, Mian M, Singer L, Humar A. An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation. Am J Transplant 2017; 17:2468–73. - PubMed
1. Nesher L, Shah DP, Ariza-Heredia EJ, et al. . Utility of the enzyme-linked immunospot interferon-γ-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients. J Infect Dis 2016; 213:1701–7. - PMC - PubMed
1. El Haddad L, Ariza-Heredia E, Shah DP, et al. . The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients. J Infect Dis 2018. In press. doi: 10.1093/infdis/jiy592. - DOI - PMC - PubMed
1. Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska A, et al. . Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients. BMC Infect Dis 2018; 18:179. - PMC - PubMed
1. Solano C, Benet I, Clari MA, et al. . Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection. Haematologica 2008; 93:1434–6. - PubMed